T 1505/23 (SIRPalpha signalling blocking antibodies/OSE) of 03.07.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T150523.20250703
- Date of decision
- 3 July 2025
- Case number
- T 1505/23
- Online on
- 1 October 2025
- Petition for review of
- -
- Application number
- 15794641.9
- IPC class
- A61K 39/00C07K 16/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions for inducing differentiation of myeloid derived suppressor cell to treat cancer and infectious diseases
- Applicant name
- OSE Immunotherapeutics
- Opponent name
- Byondis B.V.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 111(1)European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.